Elotuzumab Safety Surveillance In Japanese Patients With Relapse Or Refractory Multiple Myeloma
Clinical trial NCT02976493 · COMPLETED
Trial details
- NCT number
- NCT02976493
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-01
- Primary completion
- 2018-06-18
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.